gender; age
Item
male/female above 18 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Basal Cell Carcinoma
Item
1 or more primary histologically verified bcc, clinically assessed as of either superficial of nodular type
boolean
C0007117 (UMLS CUI [1])
pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
breastfeeding
Item
breastfeeding
boolean
C0006147 (UMLS CUI [1])
gorlins syndrome
Item
gorlin's syndrome
boolean
C0004779 (UMLS CUI [1])
porphyria
Item
porphyria
boolean
C3463940 (UMLS CUI [1])
xeroderma pigmentosum
Item
xeroderma pigmentosum
boolean
C0043346 (UMLS CUI [1])
arsenic exposure
Item
history of arsenic exposure
boolean
C0238690 (UMLS CUI [1])
hypersensitivity methyl 5-aminolevulinate
Item
known allergy to mal
boolean
C0020517 (UMLS CUI [1,1])
C1134467 (UMLS CUI [1,2])
concomitant treatment immunosuppressive medication
Item
concomitant treatment with immunosuppressive medication
boolean
C1707479 (UMLS CUI [1,1])
C0021081 (UMLS CUI [1,2])
Compliance behavior Limited Comorbidity
Item
physical or mental conditions that most likely will prevent patients attending follow-up sessions
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])